secwatch / observer
8-K filed March 10, 2023, 6:59 PM ET ticker RCUS CIK 0001724521
leadership confidence high sentiment neutral materiality 0.40

Arcus Biosciences appoints Alexander Azoy as Principal Accounting Officer

Arcus Biosciences, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert C. Goeltz II

Principal Accounting Officer
RCUS · Arcus Biosciences, Inc.
Effective
2023-03-09
Successor
Alexander Azoy
Filed
March 10, 2023, 6:59 PM ET
Concurrent with Mr. Azoy’s appointment as the Company’s Principal Accounting Officer, Robert C. Goeltz II, the Company’s Chief Financial Officer (and in such role was the Company’s Principal Financial Officer), ceased to function as the Company’s Principal Accounting Officer.
Appointed

Alexander Azoy

Principal Accounting Officer
RCUS · Arcus Biosciences, Inc.
Effective
2023-03-09
Filed
March 10, 2023, 6:59 PM ET
On March 9, 2023, the Board of Directors (the “Board”) of Arcus Biosciences, Inc. (the “Company”) appointed Alexander Azoy to serve as the Company’s Principal Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert C. Goeltz II changed role as Principal Accounting Officer at Arcus Biosciences, Inc..

Action
ceased to function as
Role
Principal Accounting Officer
Exact text from the filing
Concurrent with Mr. Azoy’s appointment as the Company’s Principal Accounting Officer, Robert C. Goeltz II, the Company’s Chief Financial Officer (and in such role was the Company’s Principal Financial Officer), ceased to function as the Company’s Principal Accounting Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Alexander Azoy was appointed as Principal Accounting Officer at Arcus Biosciences, Inc..

Action
appointed
Role
Principal Accounting Officer
Exact text from the filing
On March 9, 2023, the Board of Directors (the “Board”) of Arcus Biosciences, Inc. (the “Company”) appointed Alexander Azoy to serve as the Company’s Principal Accounting Officer.
View on SEC.gov

Arcus Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-007320
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.